Updated:
Brain Trust Accelerator Fund
Brain Trust Accelerator Fund is a Burlingame-based private equity manager focused on early-stage investments.
Brain Trust Accelerator Fund
The Brain Trust Accelerator Fund invests in early-stage companies addressing brain-related diseases. The fund has made 16 investments, including a Series B investment in NeuroTherapia on August 06, 2024. It has facilitated 3 portfolio exits, with Thirteen Lune exiting on December 23, 2024.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Burlingame
Corporate office
Burlingame, United States
Sector focus
Frequently asked questions
What is the investment focus of Brain Trust Accelerator Fund?
The firm targets early-stage private equity opportunities.
Where is Brain Trust Accelerator Fund headquartered?
The firm is based in Burlingame, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: